Product logins

Find logins to all Clarivate products below.


Biopsy Devices | Europe | 2016 | Market Analysis

The European market for biopsy devices will be primarily driven by wider implementation of national cancer screening programs, an increase in reimbursement coverage for biopsy procedures, increasing adoption of premium-priced devices, and favorable demographics; these factors will result in market growth through 2024.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for biopsy devices in Europe across a 10-year period.

Related Medtech Insights Reports

Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
In Vitro Diagnostics – Market Insights – United States
The US IVD market is expected to grow moderately, supported by rising rates of chronic and infectious conditions, a growing elderly population, and the ongoing transition to valuebased care. These…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Diabetes Care Devices – Market Insights – Europe
The European diabetes care device market will grow moderately over the forecast period, driven by a rising diabetes population, favorable reimbursement policies, ongoing device innovation, and the…